Press release
Stendomycin Salicylate Market share will expand till 2024
Stendomycin salicylate is an antifungal antibiotic that has been newly developed for controlling the disease called rose mildew found in rose flower plants. Biological name of the disease-causing fungus is Sphaerotheca pannosa var. rosae. The fungus is also known as Podosphaera pannosa. Rose mildew is a highly common foliar disease of roses. The visible white powdery growth can affect all parts of the plant that are above the ground. Poor-quality soil, high humidity, and lack of oxygen for plants are favorable conditions for this disease. It can hamper the growth and quality of the rose plant badly. The disease attacks rose plants primarily in summer, as the climatic conditions are favorable for growth of the fungus in summer. Stendomycin salicylate has been found to be highly effective in controlling the rose mildew disease.
View Report Preview:
https://www.transparencymarketresearch.com/stendomycin-salicylate-market.html
The synthesis of stendomycin salicylate is in a novice phase, with most of the research and development done on rose plants. The plants have demonstrated good response to the use of stendomycin salicylate and research has proved to be successful in controlling the disease. The market for stendomycin salicylate is still in infancy and so far, the antibiotic has not been produced commercially. Once manufactured commercially, stendomycin salicylate can witness significant demand across the globe.
High demand for rose flower plants across the globe is expected to drive the stendomycin salicylate market. Rose is one of the most consumed flowers, due to its high use, especially in festive and marriage seasons. Cut flowers of rose are also used for decoration on various festive occasions. Stendomycin salicylate can also be applied on other foliar plants such as lily, jasmine, and marigold.
Based on region, the stendomycin salicylate market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is expected to hold a significant share of the stendomycin salicylate market during the forecast period. This is due to high demand for rose flower coupled with large production of cut flowers in the region. The Netherlands is one of the leading producers of cut flowers such as rose in the region. The country also hosts one of the leading markets for flowers in the world. North America is expected to follow Europe during the forecast period.
Countries in Europe such as Sweden, Denmark, and Switzerland also produce roses in considerable numbers, which drives the demand for stendomycin salicylate in the region. The market in the region is anticipated to be driven by high demand for roses in almost all seasons, especially festive seasons. Asia Pacific is likely to follow North America. The stendomycin salicylate market in Asia Pacific is expected to expand at a rapid pace in the next few years, due to large consumer base in the region. Markets in Latin America and Middle East & Africa are also expected to expand at a steady pace during the forecast period. Countries in Africa such as Kenya and Ethiopia also produce cut flowers. This, in turn, is anticipated to raise the demand for stendomycin salicylate in Middle East & Africa.
Being at a novel phase, the stendomycin salicylate market is undergoing research and development activities. Companies that deal in the manufacture of antifungal antibiotics are leading the research and development of stendomycin salicylate. Major players operating in the global stendomycin salicylate market are Lily Research Laboratories, GlaxoSmithKline, Pfizer, Merck, Eli Lily & Co., and National Institute of Allergy and Infectious Diseases.
Request to view Sample Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20771
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stendomycin Salicylate Market share will expand till 2024 here
News-ID: 896271 • Views: …
More Releases from Transparency Market Research
Diabetes Supplements Market to Reach USD 13.4 Billion by 2031 as Preventive Nutr …
The Diabetes Supplements Market is witnessing steady expansion as rising diabetes prevalence and increasing emphasis on preventive healthcare drive demand for nutritional products that support blood sugar management and metabolic health. Valued at approximately US$ 8.4 billion in 2020, the market is projected to grow at a healthy pace and reach around US$ 13.4 billion by 2031
With diabetes emerging as one of the most pressing global health challenges, consumers are…
Drugs of Abuse Testing Market to Reach US$ 18.7 Billion by 2031, Growing at 13.5 …
The global drugs of abuse testing market was valued at US$ 5.9 Bn in 2022 and is projected to expand at a robust CAGR of 13.5% from 2023 to 2031, reaching US$ 18.7 Bn by the end of 2031. The market is witnessing strong momentum due to the rising incidence of drug abuse worldwide, increasing regulatory oversight, and the introduction of technologically advanced screening solutions.
Access key findings and insights from…
Power Lawn and Garden Equipment Market Size Forecast to USD 188.4 Billion by 203 …
Power Lawn and Garden Equipment Market Outlook 2036
The global power lawn and garden equipment market was valued at US$ 93.9 Billion in 2025 and is projected to reach US$ 188.4 Billion by 2036, expanding at a steady CAGR of 6.6% from 2026 to 2036. Market growth is driven by increasing residential landscaping activities, rising demand for battery-powered equipment, expanding commercial landscaping services, and growing consumer interest in outdoor aesthetics.
👉 Get…
Global Embedded System Market to Reach USD 211.6 Bn by 2036, Expanding at 6.5% C …
The global embedded system market is poised for steady and sustained growth over the next decade, driven by rapid digital transformation across industries. Valued at US$ 104.6 Bn in 2025, the market is projected to reach US$ 211.6 Bn by 2036, expanding at a CAGR of 6.5% from 2026 to 2036. The increasing integration of embedded systems in automotive electronics, industrial automation, and IoT-enabled devices is positioning the industry as…
More Releases for Stendomycin
Stendomycin Salicylate Market - Global Industry Analysis, Trends, and Forecast 2 …
Stendomycin salicylate is an antifungal antibiotic that has been newly developed for controlling the disease called rose mildew found in rose flower plants. Biological name of the disease-causing fungus is Sphaerotheca pannosa var. rosae. The fungus is also known as Podosphaera pannosa. Rose mildew is a highly common foliar disease of roses. The visible white powdery growth can affect all parts of the plant that are above the ground. Poor-quality…
